<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Benfluorex</id>
	<title>Benfluorex - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Benfluorex"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Benfluorex&amp;action=history"/>
	<updated>2026-04-23T19:29:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Benfluorex&amp;diff=5804488&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Benfluorex&amp;diff=5804488&amp;oldid=prev"/>
		<updated>2024-05-20T06:19:34Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Benfluorex.svg|thumb|right]] &amp;#039;&amp;#039;&amp;#039;Benfluorex&amp;#039;&amp;#039;&amp;#039; is a [[pharmaceutical drug]] that was primarily used as an [[antidiabetic]] and [[anorectic]] agent. It is chemically related to the [[fenfluramine]] family of drugs. Benfluorex was marketed under various brand names, including [[Mediator]].&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Benfluorex is a [[serotonin-norepinephrine-dopamine reuptake inhibitor]] (SNDRI) and a [[serotonin releasing agent]] (SRA). It was used to improve [[glycemic control]] in patients with [[type 2 diabetes mellitus]] and to aid in [[weight loss]].&lt;br /&gt;
&lt;br /&gt;
==Medical Uses==&lt;br /&gt;
Benfluorex was prescribed to patients with [[type 2 diabetes]] to help control blood sugar levels. It was also used as an [[anorectic]] to assist in weight reduction in obese patients.&lt;br /&gt;
&lt;br /&gt;
==Adverse Effects==&lt;br /&gt;
The use of benfluorex has been associated with serious adverse effects, including [[cardiac valvulopathy]] and [[pulmonary hypertension]]. These risks led to the withdrawal of the drug from the market in several countries.&lt;br /&gt;
&lt;br /&gt;
==Regulatory Status==&lt;br /&gt;
Benfluorex was withdrawn from the market in [[France]] in 2009 due to its association with severe [[cardiovascular]] side effects. The [[European Medicines Agency]] (EMA) recommended the suspension of marketing authorizations for benfluorex-containing medicines across the [[European Union]] in 2010.&lt;br /&gt;
&lt;br /&gt;
==Controversy==&lt;br /&gt;
The withdrawal of benfluorex was surrounded by controversy, particularly in France, where it was marketed as Mediator. The drug was linked to numerous cases of [[heart valve disease]] and [[pulmonary hypertension]], leading to significant public outcry and legal actions against the manufacturer.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Fenfluramine]]&lt;br /&gt;
* [[Type 2 diabetes mellitus]]&lt;br /&gt;
* [[Cardiac valvulopathy]]&lt;br /&gt;
* [[Pulmonary hypertension]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
{{No external links}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Withdrawn drugs]]&lt;br /&gt;
[[Category:Antidiabetic drugs]]&lt;br /&gt;
[[Category:Anorectics]]&lt;br /&gt;
[[Category:Serotonin-norepinephrine-dopamine reuptake inhibitors]]&lt;br /&gt;
[[Category:Serotonin releasing agents]]&lt;br /&gt;
[[Category:Cardiovascular toxicology]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>